10 Best Growth Stocks Under $100 to Buy Now

5. DexCom, Inc. (NASDAQ:DXCM)

Number of Hedge Fund Holders: 69

Expected EPS CAGR in the next 5 years: 22.64%

DexCom, Inc. (NASDAQ:DXCM) is a medical device company specializing in continuous glucose monitoring (CGM) systems for people with diabetes. Its CGM devices provide real-time glucose readings through a sensor, transmitter, and mobile app, eliminating the need for traditional fingerstick testing. DXCM’s technology helps patients manage blood sugar levels, detect trends, and receive alerts for high or low glucose events. The company primarily serves individuals with Type 1 and Type 2 diabetes, as well as healthcare providers and research institutions, and focuses on innovation in sensor accuracy, wearable technology, and integration with insulin pumps and digital health platforms.

DexCom, Inc. (NASDAQ:DXCM) delivered strong performance in 2024 with revenue of $4.33 billion and organic growth of 12%, while expanding its interactive base by 25% to serve 2.8-2.9 million customers globally. The company has positioned itself for future growth through several strategic initiatives, including the submission of a 15-day CGM system to FDA for review, expansion of global manufacturing capacity, and delivery of 100 basis points of operating leverage. For 2025, DXCM has provided guidance of $4.6 billion in revenue, representing 14% growth, with significant cash generation potential as evidenced by over $1 billion in EBITDA.

DexCom, Inc. (NASDAQ:DXCM) is expanding its market reach beyond traditional insulin management through Stelo, its first over-the-counter product, which has already attracted 140,000-plus users since launch. The company’s international business has reached a significant milestone of $1 billion in revenue, with the company adding 4 million people internationally over the past 3 years. Looking ahead, DXCM is focused on the 15-day rollout in 2025, continuous software updates, and development of key gestational diabetes evidence, while working on dual analyte and continuous ketone monitoring capabilities. With that being said, DXCM is one of the best growth stocks to buy under $100.